Temple University Hospital First in World to Offer New truFreeze® Spray
Cryotherapy System for Patients with Esophageal Disease
(Philadelphia, PA) – Gastroenterologists at Temple University Hospital are the first in the world to provide the truFreeze® Spray Cryotherapy System for patients suffering from esophageal disease, including Barrett’s esophagus and esophageal cancer. This minimally invasive technology involves placing a small catheter in an endoscope to spray extremely cold liquid nitrogen and ablate targeted tissue inside the esophagus. The truFreeze® Spray Cryotherapy System is a new option for the millions of people who suffer from disorders of the esophagus, the tube that propels food to the stomach.
Michael S. Smith, MD, MBA, Medical Director of Temple’s Esophageal Program, performed the hospital’s first procedures in early November. “Offering our patients spray cryotherapy in addition to other endoscopic treatments makes Temple a truly comprehensive center for the management of Barrett’s esophagus and esophageal cancer,” says Dr. Smith. “Having truFreeze® at Temple keeps us on the cutting edge of the treatment of these conditions.”
Spray cryotherapy is an outpatient procedure that typically permits patients to quickly resume normal activity. “Our first truFreeze® patients have all reported easy recoveries with minimal discomfort,” adds Dr. Smith
How spray cryotherapy works
During the procedure, a physician inserts a long tube with a camera on the end (an endoscope) through the mouth and esophagus to enable viewing of the treatment site. The physician then threads a specialized spray cryotherapy catheter through the endoscope, selects the ablation area and sprays extremely cold (-196°C) liquid nitrogen on the diseased tissue to flash freeze and destroy it. The tissue is allowed to thaw, and the freeze-thaw cycle is typically repeated several times as determined necessary by the physician. This rapid freeze and slow thaw of tissue has been proven to destroy the targeted cells without disturbing the underlying connective tissue, providing a framework for healthy cells to regenerate.
Cryotherapy, the use of extreme cold in medical applications, is a proven therapy that has been used for decades to treat diseased tissue on the skin and many parts of the body. The spray cryotherapy system being utilized at Temple University Hospital is a novel and versatile ablation option because
of its touch-less spray application, which enables physicians to address tissue of varied shapes and sizes.
The truFreeze® Spray Cryotherapy System is manufactured by CSA Medical, Inc. More information about CSA Medical can be found at https://www.csamedical.com.
Editor’s Note: Dr. Smith is a consultant for CSA Medical, Inc. About Temple Health
Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System and by Temple University School of Medicine. Temple University Health System (TUHS) is a $1.4 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System consists of Temple University Hospital (TUH), ranked among the “Best Hospitals” in the region by U.S. News & World Report; TUH-Episcopal Campus; TUH-Northeastern Campus; Fox Chase Cancer Center, an NCI-designated comprehensive cancer center; Jeanes Hospital, a community-based hospital offering medical, surgical and emergency services; Temple Transport Team, a ground and air-ambulance company; and Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices. TUHS is affiliated with Temple University School of Medicine.
Temple University School of Medicine (TUSM), established in 1901, is one of the nation’s leading medical schools. Each year, the School of Medicine educates approximately 720 medical students and 140 graduate students. Based on its level of funding from the National Institutes of Health, Temple University School of Medicine is the second-highest ranked medical school in Philadelphia and the third-highest in the Commonwealth of Pennsylvania. According to U.S. News & World Report, TUSM is among the top 10 most applied-to medical schools in the nation.